Carbonic Anhydrase Inhibitors

Carbonic anhydrase inhibitors (CAIs) are drugs used to treat glaucoma, a condition that causes pressure to build up in the eye due to an increase in fluid. CAIs work by blocking the enzyme carbonic anhydrase, which is responsible for producing bicarbonate, a key part of the fluid production process in the eye. By blocking this enzyme, CAIs reduce the pressure in the eye and prevent further damage to the optic nerve, helping to improve and maintain vision. CAIs are usually taken as eye drops or as tablets, and can provide quick and effective relief from glaucoma.

← International Journal of Glaucoma

Related Articles

3 article(s) found

Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Induce Aging by Inhibiting Telomerase Function

Full-text HTML Download PDF Download XML

Cross-Reactivity between COX-2 Inhibitors in Patients with Cross-Reactive Hypersensitivity to NSAIDs

Full-text HTML Download PDF Download XML

Natural Polyphenols as Inhibitors for the Binding of Covid-19 S-RBD with ACE-2

Full-text HTML Download PDF Download XML